---
title: "SDKX and IM Motors will collaborate to develop macromolecular drugs"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260579916.md"
description: "On October 10th, SDKX announced that the company has recently signed a cooperation agreement with the macromolecule drug development CDMO company Zhixiang Biotechnology Co., Ltd., and the two parties will collaborate on the development of macromolecule drugs"
datetime: "2025-10-10T08:41:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260579916.md)
  - [en](https://longbridge.com/en/news/260579916.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260579916.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/260579916.md) | [繁體中文](https://longbridge.com/zh-HK/news/260579916.md)


# SDKX and IM Motors will collaborate to develop macromolecular drugs

On October 10th, SDKX announced that the company has recently signed a cooperation agreement with the macromolecule drug research and development CDMO company Zhixiang Biotechnology Co., Ltd. to jointly develop macromolecule drugs

### 相关股票

- [SDKX (688136.CN)](https://longbridge.com/zh-CN/quote/688136.CN.md)

## 相关资讯与研究

- [Zydus Lifesciences Drug Desidustat Approved for Renal Anaemia in China](https://longbridge.com/zh-CN/news/279245927.md)
- [Fierce Madness Drug Name Tournament 2026: First round now open](https://longbridge.com/zh-CN/news/279472772.md)
- [Cutia Therapeutics Receives Chinese Regulatory Approval to Begin Trials of Hair Loss Drug](https://longbridge.com/zh-CN/news/279185356.md)
- [05:49 ETIIT Roorkee Inaugurates Ashok Soota Molecular Medicine Facility at BSBE to Advance Translational Biomedical Research](https://longbridge.com/zh-CN/news/279406237.md)
- [PRISM BioLab and Receptor.AI Announce Strategic Drug Discovery Collaboration](https://longbridge.com/zh-CN/news/279281269.md)